Zealand Pharma A/S
Zealand Pharma A/S
1,08 %
150,30 DKK
1,60
Kurs
150,30
Hög
152,70
Förändring
1,08 %
Låg
146,70
Uppdaterad
2019-07-19
Öppen
149,50
Factsheet for Zealand Pharma A/S
Company Profile
Description
Zealand Pharma A/S is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. Its products include soliqua 100/33/suliqua and adlyxin. The firm focuses on gastrointestinal diseases and metabolic diseases. Its product pipeline includes dasiglucagon, glepaglutide, and dual glucagon product candidates.
Key Stats
Website: http://www.zealandpharma.com
Headquarter country: Denmark
Employees: 112
Market Cap (at close 19-07-2019): DKK 5B
Fiscal Year Ends: december
Stats

Stats 2018 2017 2016 2015 2014
Price/Earnings 4,30
Forward Price/Earnings
Price/Free Cash Flow 76,20
Return on Assets 59,10 -38,00 -23,20 -18,50 -13,80
Return on Equity 70,70 -67,50 -58,00 -45,10 -22,80
Return on Invested Capital 71,90 -40,10 -20,90 -15,30 -11,50
Dividend


Dividend/Share:
Ex. Dividend Date:0001-01-01
Trailing Dividend Yield:
Payout Ratio:0,00
Date Currency Amount
Income Statement

Revenue 2018 2017 2016 2015 2014
Total Revenue 37,98 139,78 234,78 187,68 153,77
Gross Profit -0,18 0,13 0,20 0,17 0,14
Gross Margin % -465,33% 89,53% 86,60% 88,14% 91,04%
Operating Expenses 2018 2017 2016 2015 2014
EBITDA 645,00 -254,00 -122,00 -81,00 -65,00
Net income 581,00 -272,00 -154,00 -114,00 -65,00
Basic Earnings Per Share 18,94 -9,77 -6,33 -4,82 -2,87
Operating Income -0,66 -0,25 -0,12 -0,08 -0,07
Operating Margin % -1 732,22% -176,27% -49,26% -43,33% -47,82%
Cash Flow

Cash Flow 2018 2017 2016 2015 2014
Operating Cash Flow -460,00 -279,00 41,00 -225,00 -42,00
Capital Expenditures -4,00 -7,00 -3,00 -4,00 -4,00
Free Cash Flow -464,00 -286,00 38,00 -229,00 -47,00
Balance Sheet

Assets 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Current Assets 1 178,82 703,19 373,17 615,57 575,44 324,28
Long Term Assets 50,97 34,05 321,45 19,12 21,32 22,63
Total Assets 1 229,80 737,24 694,63 634,69 596,76 346,91
Liabilities 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Total Current Liabilities 113,52 75,78 87,55 69,51 76,76 30,77
Long Term Liabilities 132,99 328,88 312,95
Total Liabilities 208,77 416,43 382,46
Equity 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Retained Earnings -894,00 -1 461,48 -1 189,21 227,88 229,64 292,95
Treasury Stock
Total Stockholder Equity 1 116,28 528,47 278,19 252,23 252,83 316,14
Net Tangible Assets 1 116,28 528,47 278,19 252,23 252,83 316,14